- RobertPhillips900 Sep 05, 2017 at 05:29: PM
RobertPhillips900
new user
$LCI said it won the U.S. FDA's approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules, USP in the strengths of 20mg and 40mg. This is used to treat gastroesophageal reflux disease.